留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

微小RNA工程化外泌体在糖尿病创面中的作用研究进展

简喜超 邓呈亮

简喜超, 邓呈亮. 微小RNA工程化外泌体在糖尿病创面中的作用研究进展[J]. 中华烧伤与创面修复杂志, 2024, 40(2): 190-195. DOI: 10.3760/cma.j.cn501225-20230721-00011.
引用本文: 简喜超, 邓呈亮. 微小RNA工程化外泌体在糖尿病创面中的作用研究进展[J]. 中华烧伤与创面修复杂志, 2024, 40(2): 190-195. DOI: 10.3760/cma.j.cn501225-20230721-00011.
Jian XC,Deng CL.Research advances on the role of microRNA engineered exosomes in diabetic wounds[J].Chin J Burns Wounds,2024,40(2):190-195.DOI: 10.3760/cma.j.cn501225-20230721-00011.
Citation: Jian XC,Deng CL.Research advances on the role of microRNA engineered exosomes in diabetic wounds[J].Chin J Burns Wounds,2024,40(2):190-195.DOI: 10.3760/cma.j.cn501225-20230721-00011.

微小RNA工程化外泌体在糖尿病创面中的作用研究进展

doi: 10.3760/cma.j.cn501225-20230721-00011
基金项目: 

贵州省科技计划项目(黔科合基础-ZK[2021]重点011、黔科合支撑[2021]一般079、黔科合基础[2020]1Y331) ZK2021-011, 2021-079, 2020-1Y331

省部共建协同创新中心项目 2020-39

详细信息
    通讯作者:

    邓呈亮,Email:cheliadeng@sina.com

Research advances on the role of microRNA engineered exosomes in diabetic wounds

Funds: 

Science and Technology Plan Project of Guizhou Province of China ZK2021-011, 2021-079, 2020-1Y331

Collaborative Innovation Center of Chinese Ministry of Education 2020-39

More Information
  • 摘要: 糖尿病创面是糖尿病患者常见的并发症之一,治疗较为困难。目前,糖尿病创面的治疗方法包括清创、功能性敷料覆盖、负压治疗、骨水泥填充、皮肤移植等。微小RNA(miRNA)工程化外泌体具有减轻炎症、刺激血管生成、促进胶原沉积和再上皮化等功能,在糖尿病创面修复中展现出巨大潜力,相关研究正在积极开展。该文对糖尿病创面的病理生理特征、miRNA与外泌体的特性、外泌体负载miRNA的工程化方法和miRNA工程化外泌体促进糖尿病创面愈合的机制进行综述,以期为miRNA工程化外泌体在糖尿病创面中的临床应用提供参考依据。

     

  • 参考文献(43)

    [1] SunH,SaeediP,KarurangaS,et al.IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022,183:109119.DOI: 10.1016/j.diabres.2021.109119.
    [2] ArmstrongDG,BoultonA,BusSA.Diabetic foot ulcers and their recurrence[J].N Engl J Med,2017,376(24):2367-2375.DOI: 10.1056/NEJMra1615439.
    [3] 中国医疗保健国际交流促进会糖尿病足病分会,国际血管联盟中国分部糖尿病足病专家委员会.中国糖尿病足诊治指南[J].中国临床医生杂志,2020,48(1):19-27.DOI: 10.3969/j.issn.2095-8552.2020.01.007.
    [4] 海峡两岸医药卫生交流协会烧创伤暨组织修复专委会.负压伤口疗法在糖尿病足创面治疗中的应用全国专家共识(2021版)[J].中华烧伤杂志,2021,37(6):508-518.DOI: 10.3760/cma.j.cn501120-20210107-00010.
    [5] WeiP, ZhongC, YangX, et al. Exosomes derived from human amniotic epithelial cells accelerate diabetic wound healing via PI3K-AKT-mTOR-mediated promotion in angiogenesis and fibroblast function[J/OL]. Burns Trauma,2020,8: tkaa020[2023-07-21]. https://pubmed.ncbi.nlm.nih.gov/32923490/. DOI: 10.1093/burnst/tkaa020.
    [6] SoheilifarMH,Masoudi-KhoramN.Wound dressings incorporating microRNAs: innovative therapy for diabetic wound treatment[J].Iran J Basic Med Sci,2022,25(9):1042-1044.DOI: 10.22038/IJBMS.2022.67236.14739.
    [7] MouraJ,MadureiraP,LealEC,et al.Immune aging in diabetes and its implications in wound healing[J].Clin Immunol,2019,200:43-54.DOI: 10.1016/j.clim.2019.02.002.
    [8] ChenT, SongP, HeM, et al. Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway[J/OL]. Burns Trauma, 2023, 11: tkad003[2023-07-21]. https://pubmed.ncbi.nlm.nih.gov/37251708/. DOI: 10.1093/burnst/tkad003.
    [9] CatrinaSB,ZhengX.Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers[J].Diabetes Metab Res Rev,2016,32 Suppl 1:179-185.DOI: 10.1002/dmrr.2742.
    [10] PetkovicM,SørensenAE,LealEC,et al.Mechanistic actions of microRNAs in diabetic wound healing[J].Cells,2020,9(10):2228.DOI: 10.3390/cells9102228.
    [11] BartelDP.MicroRNAs: genomics, biogenesis, mechanism, and function[J].Cell,2004,116(2):281-297.DOI: 10.1016/s0092-8674(04)00045-5.
    [12] PegtelDM,GouldSJ.Exosomes[J].Annu Rev Biochem,2019,88:487-514.DOI: 10.1146/annurev-biochem-013118-111902.
    [13] GualdiG,CostantiniE,RealeM,et al.Wound repair and extremely low frequency-electromagnetic field: insight from in vitro study and potential clinical application[J].Int J Mol Sci,2021,22(9):5037.DOI: 10.3390/ijms22095037.
    [14] DesmetCM,PréatV,GallezB.Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing[J].Adv Drug Deliv Rev,2018,129:262-284.DOI: 10.1016/j.addr.2018.02.001.
    [15] JonesJI,NguyenTT,PengZ,et al.Targeting MMP-9 in diabetic foot ulcers[J].Pharmaceuticals (Basel),2019,12(2):79.DOI: 10.3390/ph12020079.
    [16] FalangaV.Wound healing and its impairment in the diabetic foot[J].Lancet,2005,366(9498):1736-1743.DOI: 10.1016/S0140-6736(05)67700-8.
    [17] BartelDP.MicroRNAs: target recognition and regulatory functions[J].Cell,2009,136(2):215-233.DOI: 10.1016/j.cell.2009.01.002.
    [18] LewisBP,BurgeCB,BartelDP.Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J].Cell,2005,120(1):15-20.DOI: 10.1016/j.cell.2004.12.035.
    [19] ZhangY,LiuY,LiuH,et al.Exosomes: biogenesis, biologic function and clinical potential[J].Cell Biosci,2019,9:19.DOI: 10.1186/s13578-019-0282-2.
    [20] MartinsTS,VazM,HenriquesAG.A review on comparative studies addressing exosome isolation methods from body fluids[J].Anal Bioanal Chem,2023,415(7):1239-1263.DOI: 10.1007/s00216-022-04174-5.
    [21] ManzariMT,ShamayY,KiguchiH,et al.Targeted drug delivery strategies for precision medicines[J].Nat Rev Mater,2021,6(4):351-370.DOI: 10.1038/s41578-020-00269-6.
    [22] ChoiH,ChoiY,YimHY,et al.Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes[J].Tissue Eng Regen Med,2021,18(4):499-511.DOI: 10.1007/s13770-021-00361-0.
    [23] LvQ,DengJ,ChenY,et al.Engineered human adipose stem-cell-derived exosomes loaded with miR-21-5p to promote diabetic cutaneous wound healing[J].Mol Pharm,2020,17(5):1723-1733.DOI: 10.1021/acs.molpharmaceut.0c00177.
    [24] EsmaeiliA,HosseiniS,Baghaban EslaminejadM.Engineered-extracellular vesicles as an optimistic tool for microRNA delivery for osteoarthritis treatment[J].Cell Mol Life Sci,2021,78(1):79-91.DOI: 10.1007/s00018-020-03585-w.
    [25] PomattoM,BussolatiB,D'AnticoS,et al.Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs[J].Mol Ther Methods Clin Dev,2019,13:133-144.DOI: 10.1016/j.omtm.2019.01.001.
    [26] ZhangD,LeeH,ZhuZ,et al.Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo[J].Am J Physiol Lung Cell Mol Physiol,2017,312(1):L110-L121.DOI: 10.1152/ajplung.00423.2016.
    [27] AkersJC,RamakrishnanV,YangI,et al.Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid[J].Cancer Biomark,2016,17(2):125-132.DOI: 10.3233/CBM-160609.
    [28] GondaliyaP,SayyedAA,BhatP,et al.Mesenchymal stem cell-derived exosomes loaded with miR-155 inhibitor ameliorate diabetic wound healing[J].Mol Pharm,2022,19(5):1294-1308.DOI: 10.1021/acs.molpharmaceut.1c00669.
    [29] MondalJ,PillarisettiS,JunnuthulaV,et al.Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications[J].J Control Release,2023,353:1127-1149.DOI: 10.1016/j.jconrel.2022.12.027.
    [30] YaoY,JiangY,SongJ,et al.Exosomes as potential functional nanomaterials for tissue engineering[J].Adv Healthc Mater,2023,12(16):e2201989.DOI: 10.1002/adhm.202201989.
    [31] LiQ,HuW,HuangQ,et al.MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1[J].Signal Transduct Target Ther,2023,8(1):62.DOI: 10.1038/s41392-022-01263-w.
    [32] YangZ,ShiJ,XieJ,et al.Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation[J].Nat Biomed Eng,2020,4(1):69-83.DOI: 10.1038/s41551-019-0485-1.
    [33] ChaJM,ShinEK,SungJH,et al.Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells[J].Sci Rep,2018,8(1):1171.DOI: 10.1038/s41598-018-19211-6.
    [34] BiH,FeiQ,LiR,et al.Disruption of miRNA sequences by TALENs and CRISPR/Cas9 induces varied lengths of miRNA production[J].Plant Biotechnol J,2020,18(7):1526-1536.DOI: 10.1111/pbi.13315.
    [35] Da SilvaJ,LealEC,CarvalhoE,et al.Innovative functional biomaterials as therapeutic wound dressings for chronic diabetic foot ulcers[J].Int J Mol Sci,2023,24(12):9900.DOI: 10.3390/ijms24129900.
    [36] TaoSC,GuoSC,LiM,et al.Chitosan wound dressings incorporating exosomes derived from microRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model[J].Stem Cells Transl Med,2017,6(3):736-747.DOI: 10.5966/sctm.2016-0275.
    [37] SathyarajWV,PrabakaranL,BhoopathyJ,et al.Therapeutic efficacy of polymeric biomaterials in treating diabetic wounds-an upcoming wound healing technology[J].Polymers (Basel),2023,15(5):1205.DOI: 10.3390/polym15051205.
    [38] ZhaoX,FuL,ZouH,et al.Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair[J].J Nanobiotechnology,2023,21(1):176.DOI: 10.1186/s12951-023-01886-3.
    [39] GeL,WangK,LinH,et al.Engineered exosomes derived from miR-132-overexpresssing adipose stem cells promoted diabetic wound healing and skin reconstruction[J].Front Bioeng Biotechnol,2023,11:1129538.DOI: 10.3389/fbioe.2023.1129538.
    [40] ManuelliV,PecorariC,FilomeniG,et al.Regulation of redox signaling in HIF-1-dependent tumor angiogenesis[J].FEBS J,2022,289(18):5413-5425.DOI: 10.1111/febs.16110.
    [41] YanC,ChenJ,WangC,et al.Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis[J].Drug Deliv,2022,29(1):214-228.DOI: 10.1080/10717544.2021.2023699.
    [42] YangC,LuoL,BaiX,et al.Highly-expressed micoRNA-21 in adipose derived stem cell exosomes can enhance the migration and proliferation of the HaCaT cells by increasing the MMP-9 expression through the PI3K/AKT pathway[J].Arch Biochem Biophys,2020,681:108259.DOI: 10.1016/j.abb.2020.108259.
    [43] Rodríguez-RodríguezN,Martínez-JiménezI,García-OjalvoA,et al.Wound chronicity, impaired immunity and infection in diabetic patients[J].MEDICC Rev,2022,24(1):44-58.DOI: 10.37757/MR2021.V23.N3.8.
  • 加载中
计量
  • 文章访问数:  175
  • HTML全文浏览量:  106
  • PDF下载量:  33
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-07-21
  • 网络出版日期:  2024-02-26

目录

    /

    返回文章
    返回